Paula Restrepo

Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation

A. Laganà, S. Jagannath, P. Poulikakos, 2022, Journal of Hematology & Oncology.

Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation

A. Laganà, S. Jagannath, P. Poulikakos, 2022, Journal of Hematology & Oncology.

Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications

J. Dudley, A. Laganà, J. Keats, 2020, Science advances.

A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma

A. Laganà, S. Jagannath, D. Madduri, 2022, medRxiv.

Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation

A. Laganà, S. Jagannath, P. Poulikakos, 2022, Journal of Hematology & Oncology.

Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation

A. Laganà, S. Jagannath, P. Poulikakos, 2023, Journal of Hematology & Oncology.

Improving Deep Vein Thrombosis Prophylaxis With Mechanical Modalities in Surgical Intensive Care Unit

D. Carroll, Paula Restrepo, D. L. Jameson, 2015, Journal of nursing care quality.